Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human AGRP ELISA Kit (AC3757)
Cat.#: ASET-2346
Specifications
Description Human AGRP ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human AGRP concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 10.03 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 150-2400 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1522 Human P Cadherin ELISA Kit (AC2933) Quantitative inquiry ASET-2310 Human C1QB ELISA Kit (AC3721) Quantitative inquiry ASET-1429 Human PMP22 ELISA Kit (AC2840) Quantitative inquiry ASET-2210 Monkey TIMP1 ELISA Kit (AC3621) Quantitative inquiry ASET-1182 Human CDK5 ELISA Kit (AC2593) Quantitative inquiry ASET-1397 Human beta III Tubulin ELISA Kit (AC2808) Quantitative inquiry ASET-1525 Human beta Catenin ELISA Kit (AC2936) Quantitative inquiry ASET-1843 Human CRCP ELISA Kit (AC3254) Quantitative inquiry ASET-1579 Human CNTN5 ELISA Kit (AC2990) Quantitative inquiry ASET-1070 Human DLL1 ELISA Kit (AC2481) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket